Overview

Safety and Tolerability of Modafinil for Methamphetamine Dependence

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This 7 week, open-label pilot clinical trial will examine the safety and tolerability of modafinil up to 400mg/day as a potential treatment to reduce methamphetamine use in methamphetamine-dependent volunteers.
Phase:
Phase 2
Details
Lead Sponsor:
University of Arkansas
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Armodafinil
Methamphetamine
Modafinil